{"id":"https://openalex.org/W4404975690","doi":"https://doi.org/10.1158/1535-7163.27951045","title":"Figure S5 from Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity","display_name":"Figure S5 from Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity","publication_year":2024,"publication_date":"2024-12-03","ids":{"openalex":"https://openalex.org/W4404975690","doi":"https://doi.org/10.1158/1535-7163.27951045"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.27951045","doi":"https://doi.org/10.1158/1535-7163.27951045","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.27951045","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.27951045","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083063156","display_name":"Priyanka Shailendra Rana","orcid":"https://orcid.org/0000-0001-5774-4383","observed_orcids":["https://orcid.org/0000-0001-5774-4383"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Priyanka S. Rana","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5774-4383","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012867231","display_name":"James John Ignatz-Hoover","orcid":"https://orcid.org/0000-0001-8196-2655","observed_orcids":["https://orcid.org/0000-0001-8196-2655"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James J. Ignatz-Hoover","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8196-2655","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065393544","display_name":"Chunna Guo","orcid":"https://orcid.org/0000-0001-6075-7441","observed_orcids":["https://orcid.org/0000-0001-6075-7441"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chunna Guo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6075-7441","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059619254","display_name":"Amber L. Mosley","orcid":"https://orcid.org/0000-0001-5822-2894","observed_orcids":["https://orcid.org/0000-0001-5822-2894"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amber L. Mosley","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5822-2894","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083283435","display_name":"Ehsan Malek","orcid":"https://orcid.org/0000-0003-4719-4327","observed_orcids":["https://orcid.org/0000-0003-4719-4327"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ehsan Malek","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4719-4327","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109734528","display_name":"Yuriy Federov","orcid":"https://orcid.org/0000-0001-9513-8341","observed_orcids":["https://orcid.org/0000-0001-9513-8341"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuriy Federov","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9513-8341","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025223840","display_name":"Drew Adams","orcid":"https://orcid.org/0000-0002-3038-336X","observed_orcids":["https://orcid.org/0000-0002-3038-336X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Drew J. Adams","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3038-336X","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5035898667","display_name":"James Joseph Driscoll","orcid":"https://orcid.org/0000-0001-8364-0617","observed_orcids":["https://orcid.org/0000-0001-8364-0617"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James J. Driscoll","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8364-0617","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6362000107765198,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6362000107765198,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.15539999306201935,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.094200000166893,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/compound-a","display_name":"compound A","score":0.8629999756813049},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.8840000033378601},{"id":"https://openalex.org/keywords/mhc-class-i-expression","display_name":"MHC class I expression","score":0.8820000290870667},{"id":"https://openalex.org/keywords/hla-abc","display_name":"HLA-ABC","score":0.8899999856948853},{"id":"https://openalex.org/keywords/hla-b","display_name":"HLA-B","score":0.7950000166893005},{"id":"https://openalex.org/keywords/neoantigens","display_name":"neoantigens","score":0.8069999814033508},{"id":"https://openalex.org/keywords/immunopeptidome","display_name":"immunopeptidome","score":0.9150000214576721},{"id":"https://openalex.org/keywords/cd8-t-cell-cytotoxicity","display_name":"CD8+ T cell cytotoxicity","score":0.8870000243186951},{"id":"https://openalex.org/keywords/t-cell-exhaustion","display_name":"T cell exhaustion","score":0.6579999923706055},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.9769999980926514},{"id":"https://openalex.org/keywords/tim-3","display_name":"TIM-3","score":0.7179999947547913},{"id":"https://openalex.org/keywords/ctla-4","display_name":"CTLA-4","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lag-3","display_name":"LAG-3","score":0.9980000257492065},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.625},{"id":"https://openalex.org/keywords/u266-cells","display_name":"U266 cells","score":1.0}],"concepts":[{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.7036336064338684},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.6502234935760498},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.6281849145889282},{"id":"https://openalex.org/C170627219","wikidata":"https://www.wikidata.org/wiki/Q13218497","display_name":"MHC class I","level":4,"score":0.5257545113563538},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5249167084693909},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5020625591278076},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.4941442310810089},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.4261532127857208},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3413127362728119},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2799530625343323},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.26976969838142395},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2122875154018402},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16544687747955322},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.08544641733169556}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.27951045","doi":"https://doi.org/10.1158/1535-7163.27951045","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.27951045","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.27951045","doi":"https://doi.org/10.1158/1535-7163.27951045","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.27951045","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9789000153541565}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4404975981","https://openalex.org/W7165005243","https://openalex.org/W4404975781","https://openalex.org/W4404976104","https://openalex.org/W4404975727","https://openalex.org/W4393075364","https://openalex.org/W7164987558","https://openalex.org/W4402072240","https://openalex.org/W7165013701","https://openalex.org/W4404975833"],"abstract_inverted_index":{"Figure":[0],"S5.":[1],"Effect":[2,181,239],"of":[3,86,95,116,141,182,188,223,240,265],"Compound":[4,17,39,62,90,122,157,169,183,212,241,271],"A":[5,18,40,63,91,123,170,184,213,242,253,272],"on":[6,185,243],"pan-MHC-I":[7,22],"expression.":[8],"a.":[9],"ARH77":[10,55,189],"and":[11,19,46,56,72,106,113,118,143,190,198,203,214,231,235,269,290],"U266":[12,57,191],"cells":[13,58,97,109,135,192,202,226],"were":[14,32,59,70,136,174,206,249,260],"treated":[15,208,250],"with":[16,21,38,61,74,121,156,166,176,196,209,251],"probed":[20],"or":[23,167,194,210],"MHC-I":[24],"subtype":[25],"allele-specific":[26],"antibodies":[27],"after":[28,67,257],"which":[29,68,98,129,258],"the":[30,83,186,215,220],"samples":[31],"analyzed":[33],"by":[34,101,229],"flow":[35,236],"cytometry.":[36,237],"Pretreatment":[37,115],"significantly":[41],"increased":[42,92],"pan-MHC":[43],"class-I":[44],"HLA-ABC":[45],"HLA-B":[47],"surface":[48,263,279],"presentation":[49],"in":[50,125,277,287],"all":[51],"MMCLs":[52,117],"assayed.":[53],"b.":[54],"pre-treated":[60,155],"for":[64,79,103,254,262],"48":[65],"h":[66,81,256],"they":[69,259],"washed":[71],"co-cultured":[73,137],"healthy":[75],"CD8+":[76,177,199,204,247],"cytotoxic":[77],"T-cells":[78,119,145,178,205,248],"18":[80],"at":[82,110,138],"E:T":[84,111,139],"ratios":[85,140],"1:1,":[87],"2:1and":[88],"3:1.":[89,114,144],"CTL-mediated":[93],"cytotoxicity":[94],"tumor":[96],"was":[99,130,160,227,285],"measured":[100],"gating":[102],"CD138,":[104],"Annexin-V":[105],"PI":[107],"positive":[108],"2:1":[112,142],"alone":[120,146,193],"resulted":[124],"\u223c5-10%":[126],"cell":[127,152,163],"death":[128,153,164],"enhanced":[131],"further":[132],"when":[133,154],"MM":[134,162,201],"also":[147],"did":[148],"not":[149],"show":[150],"significant":[151,283],"A.":[158],"There":[159],"<5%":[161],"detected":[165],"without":[168,211],"treatment.":[171],"Similar":[172],"results":[173],"observed":[175,286],"alone.":[179],"c.":[180,238],"viability":[187],"combined":[195],"ICIs":[197],"T-cells.":[200],"separately":[207],"indicated":[216,224],"agents.":[217],"Following":[218],"co-culture,":[219],"relative":[221],"percent":[222],"viable":[225],"quantitated":[228],"annexin-V":[230],"propidium":[232],"iodide":[233],"staining":[234],"T-cell":[244],"exhaustion":[245],"markers.":[246],"compound":[252],"24":[255],"assessed":[261],"expression":[264],"PD-1,":[266],"TIM-3,":[267,288],"CTLA-4,":[268,289],"LAG-3.":[270,291],"induced":[273],"a":[274],"marked":[275],"decrease":[276],"PD-1":[278],"expression,":[280],"while":[281],"no":[282],"change":[284]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2024-12-04T00:00:00"}